Anavex Life Sciences Corp.
US ˙ NasdaqGS ˙ US0327973006

SecurityAVXL / Anavex Life Sciences Corp.
InstitutionState Street Corp
Latest Disclosed Ownership3,642,702 shares
Ownership 4.44%
State Street Corp ownership in AVXL / Anavex Life Sciences Corp.

2024-01-22 - State Street Corp has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,642,702 shares of Anavex Life Sciences Corp. (US:AVXL). This represents 4.44 percent ownership of the company. In their previous filing dated 2023-02-09 , State Street Corp had reported owning 5,812,605 shares, indicating a decrease of -37.33 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2024-01-22 2024-01-22 13G/A 5,812,605 3,642,702 -37.33 4.44 -40.48
2023-02-09 2023-02-09 13G/A 3,834,034 5,812,605 51.61 7.46 48.02
2022-02-09 2022-02-09 13G 3,834,034 5.04

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 4,512,028 128,622 2.93 13,852 -11.23 0.0005
2026-02-13 2025-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 4,383,406 1,096,288 33.35 15,605 -46.66 0.0005
2025-11-14 2025-09-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 3,287,118 338,310 11.47 29,255 7.60 0.0010
2025-08-14 2025-06-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 2,948,808 -265,448 -8.26 27,188 -1.41 0.0010
2025-05-15 2025-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 3,214,256 802,327 33.26 27,578 6.46 0.0011
2025-02-14 2024-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 2,411,929 -654,018 -21.33 25,904 48.75 0.0010
2024-11-14 2024-09-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 3,065,947 -674,409 -18.03 17,415 10.33 0.0007
2024-08-14 2024-06-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 3,740,356 -3,558,651 -48.76 15,784 -57.51 0.0007
2024-05-15 2024-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 7,299,007 3,656,305 100.37 37,152 9.55 0.0017
2024-02-14 2023-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 3,642,702 17,253 0.48 33,914 42.82 0.0016
2023-11-14 2023-09-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 3,625,449 -783,488 -17.77 23,747 -33.75 0.0013
2023-08-14 2023-06-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 4,408,937 -1,268,439 -22.34 35,845 -26.33 0.0019
2023-05-15 2023-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 5,677,376 -135,229 -2.33 48,655 -9.60 0.0027
2023-05-15 2022-12-31 13F/A-99 ANAVEX LIFE SCIENCES COM NEW 032797300 5,812,605 1,451,167 33.27 53,825 19.58 0.0032
2023-05-15 2022-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 5,812,605 1,451,167 53,825 0.0032
2022-11-15 2022-09-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 4,361,438 -127,807 -2.85 45,010 0.16 0.0028
2022-08-15 2022-06-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 4,489,245 -1,088,011 -19.51 44,937 -34.55 0.0027
2022-05-16 2022-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 5,577,256 1,743,222 45.47 68,656 3.27 0.0034
2022-02-14 2021-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 3,834,034 -331,386 -7.96 66,482 -11.08 0.0032
2021-11-15 2021-09-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 4,165,420 93,447 2.29 74,769 -19.68 0.0040
2021-08-16 2021-06-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 4,071,973 1,324,794 48.22 93,085 126.65 0.0049
2021-07-09 2021-03-31 13F/A-1 ANAVEX LIFE SCIENCES COM NEW 032797300 2,747,179 1,872,614 214.12 41,070 769.57 0.0024
2021-05-17 2021-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 2,747,179 1,872,614 41,070 0.0024
2021-02-16 2020-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 874,565 -15,925 -1.79 4,723 16.56 0.0003
2020-11-10 2020-09-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 890,490 14,119 1.61 4,052 -6.03 0.0003
2020-08-14 2020-06-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 876,371 53,594 6.51 4,312 66.36 0.0003
2020-06-19 2020-03-31 13F/A-1 ANAVEX LIFE SCIENCES COM NEW 032797300 822,777 14,767 1.83 2,592 23.84 0.0002
2020-05-11 2020-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 822,777 14,767 2,592 227.6298
2020-02-06 2019-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 808,010 24,084 3.07 2,093 -15.50 0.0001
2019-11-14 2019-09-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 783,926 149,644 23.59 2,477 15.86 0.0002
2019-08-14 2019-06-30 13F ANAVEX LIFE SCIENCES COM NEW 032797300 634,282 581,621 1,104.46 2,138 1,227.95 0.0002
2019-05-15 2019-03-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 52,661 -1,143 -2.12 161 91.67 0.0000
2019-02-12 2018-12-31 13F ANAVEX LIFE SCIENCES COM NEW 032797300 53,804 -1,362 -2.47 84 -44.37 0.0000
2018-11-09 2018-09-30 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 55,166 -17,057 -23.62 151 -20.11 0.0000
2018-08-14 2018-06-30 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 72,223 -593,610 -89.15 189 -89.71 0.0000
2018-05-15 2018-03-31 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 665,833 41,194 6.59 1,837 -8.65 0.0002
2018-02-14 2017-12-31 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 624,639 17,459 2.88 2,011 -20.04 0.0002
2017-11-14 2017-09-30 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 607,180 3,854 0.64 2,515 -21.65 0.0002
2017-08-14 2017-06-30 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 603,326 79,516 15.18 3,210 6.75 0.0003
2017-05-15 2017-03-31 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 523,810 132,745 33.94 3,007 94.13 0.0003
2017-02-09 2016-12-31 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 391,065 83,716 27.24 1,549 39.05 0.0001
2017-01-13 2016-09-30 13F/A-1 ANAVEX LIFE SCIENCES Common equity shares 032797300 307,349 218,377 245.44 1,114 104.78 0.0001
2016-11-14 2016-09-30 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 307,349 1,114
2016-08-12 2016-06-30 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 88,972 69,172 349.35 544 460.82 0.0001
2016-05-20 2016-03-31 13F/A-1 ANAVEX LIFE SCIENCES Common equity shares 032797300 19,800 1,200 6.45 97 -5.83 0.0000
2016-05-12 2016-03-31 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 19,800 97
2016-02-16 2015-12-31 13F ANAVEX LIFE SCIENCES Common equity shares 032797300 18,600 18,600 103 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.